NASDAQ:OTLK

Outlook Therapeutics Stock Predictions

etoro logo Buy OTLK
*Your capital is at risk
$0.81
-0.0038 (-0.467%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

OTLK Prediction Chart

OTLK Predictions History

Latest community submissions for OTLK.
Predictor Target Session Target Price Result Direction Accuracy Score
Aug 20, 2025 Bullish $2.39 X 0
Aug 19, 2025 $2.69 -3.02% $2.63 V 97.86% 1
Aug 19, 2025 $2.72 -1.89% $2.63 V 96.67% 1
Aug 19, 2025 Bullish $2.63 X 0
Aug 18, 2025 $2.27 -2.96% $2.77 X 81.98% 0
Aug 18, 2025 $2.30 -1.85% $2.77 X 82.91% 0
Aug 18, 2025 $2.50 +6.84% $2.77 V 90.25% 1
Aug 15, 2025 $2.36 -2.72% $2.34 V 98.97% 2
Aug 15, 2025 $2.39 -1.70% $2.34 V 97.92% 1
Aug 15, 2025 Bullish $2.34 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for OTLK with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT OUTLOOK THERAPEUTICS INC.
Outlook Therapeutics
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and lice...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE